"Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
    
			
			
				
				
					
						| Descriptor ID | D016518 | 
					
						| MeSH Number(s) | C04.557.465.625.650.595.610.500 C04.557.580.600.580.590.655 C04.557.580.600.610.595.610.500 C04.700.645.655 C09.218.807.800.675.500 C09.647.675.500 C10.292.225.750.500 C10.292.910.600.500 C10.562.600.750 C10.574.500.549.700 C16.320.400.560.700 C16.320.700.645.655 | 
					
						| Concept/Terms | Neurofibromatosis 2Neurofibromatosis 2Neurofibromatosis, Central, NF2Neurofibromatosis, Central, NF 2Bilateral Acoustic NeurofibromatosisAcoustic Neurofibromatoses, BilateralAcoustic Neurofibromatosis, BilateralBilateral Acoustic NeurofibromatosesNeurofibromatoses, Bilateral AcousticNeurofibromatosis, Bilateral AcousticNeurofibromatosis IINeurofibromatosis IIsNeurofibromatosis, central typeNeurofibromatosis Type 2Neurofibromatosis, Type IINeurofibromatoses, Type IIType II NeurofibromatosesType II NeurofibromatosisNeurofibromatosis, Type 2Neurofibromatoses, Type 2Type 2 NeurofibromatosesType 2 NeurofibromatosisNF2 (Neurofibromatosis 2)NF2s (Neurofibromatosis 2)Neurofibromatosis, Central NF2Central NF2 NeurofibromatosesCentral NF2 NeurofibromatosisNeurofibromatoses, Central NF2Central NeurofibromatosisCentral NeurofibromatosesNeurofibromatoses, CentralNeurofibromatosis, CentralNeurofibromatosis, Acoustic, BilateralNeurofibromatosis Type II
 Neuroma, Acoustic, BilateralNeuroma, Acoustic, BilateralAcoustic Neurinoma, BilateralAcoustic Neurinomas, BilateralBilateral Acoustic NeurinomaBilateral Acoustic NeurinomasNeurinoma, Bilateral AcousticNeurinomas, Bilateral Acoustic
 Schwannoma, Acoustic, BilateralSchwannoma, Acoustic, BilateralAcoustic Schwannomas, BilateralAcoustic Schwannoma, BilateralBilateral Acoustic SchwannomaBilateral Acoustic SchwannomasSchwannoma, Bilateral AcousticSchwannomas, Bilateral Acoustic
 Familial Acoustic NeuromasFamilial Acoustic NeuromasAcoustic Neuroma, FamilialAcoustic Neuromas, FamilialFamilial Acoustic NeuromaNeuroma, Familial AcousticNeuromas, Familial Acoustic
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Neurofibromatosis 2".
				
					
						- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Neuroectodermal Tumors [C04.557.465.625]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Neurilemmoma [C04.557.465.625.650.595]
- Neuroma, Acoustic [C04.557.465.625.650.595.610]
- Neurofibromatosis 2 [C04.557.465.625.650.595.610.500]
- Neoplasms, Nerve Tissue [C04.557.580]
- Nerve Sheath Neoplasms [C04.557.580.600]
- Neurofibroma [C04.557.580.600.580]
- Neurofibromatoses [C04.557.580.600.580.590]
- Neurofibromatosis 2 [C04.557.580.600.580.590.655]
- Neuroma [C04.557.580.600.610]
- Neurilemmoma [C04.557.580.600.610.595]
- Neuroma, Acoustic [C04.557.580.600.610.595.610]
- Neurofibromatosis 2 [C04.557.580.600.610.595.610.500]
- Neoplastic Syndromes, Hereditary [C04.700]
- Neurofibromatoses [C04.700.645]
- Neurofibromatosis 2 [C04.700.645.655]
- Otorhinolaryngologic Diseases [C09]
- Ear Diseases [C09.218]
- Retrocochlear Diseases [C09.218.807]
- Vestibulocochlear Nerve Diseases [C09.218.807.800]
- Neuroma, Acoustic [C09.218.807.800.675]
- Neurofibromatosis 2 [C09.218.807.800.675.500]
- Otorhinolaryngologic Neoplasms [C09.647]
- Neuroma, Acoustic [C09.647.675]
- Neurofibromatosis 2 [C09.647.675.500]
- Nervous System Diseases [C10]
- Cranial Nerve Diseases [C10.292]
- Cranial Nerve Neoplasms [C10.292.225]
- Neuroma, Acoustic [C10.292.225.750]
- Neurofibromatosis 2 [C10.292.225.750.500]
- Vestibulocochlear Nerve Diseases [C10.292.910]
- Neuroma, Acoustic [C10.292.910.600]
- Neurofibromatosis 2 [C10.292.910.600.500]
- Neurocutaneous Syndromes [C10.562]
- Neurofibromatoses [C10.562.600]
- Neurofibromatosis 2 [C10.562.600.750]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Neurofibromatoses [C10.574.500.549]
- Neurofibromatosis 2 [C10.574.500.549.700]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Neurofibromatoses [C16.320.400.560]
- Neurofibromatosis 2 [C16.320.400.560.700]
- Neoplastic Syndromes, Hereditary [C16.320.700]
- Neurofibromatoses [C16.320.700.645]
- Neurofibromatosis 2 [C16.320.700.645.655]
 
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Neurofibromatosis 2".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Neurofibromatosis 2" by people in this website by year, and whether "Neurofibromatosis 2" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2014 | 2 | 0 | 2 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Neurofibromatosis 2" by people in Profiles.
						
					
								- 
								Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J Neurooncol. 2019 Sep; 144(2):239-248. 
- 
								Bilateral Combined Hamartomas of the Retina and Retinal Pigment Epithelium as the Presenting Feature of Neurofibromatosis Type 2 (Wishart Type). J Pediatr Ophthalmol Strabismus. 2014 May 28; 51 Online:e33-6. 
- 
								Bilateral combined hamartomas of the retina and retinal pigment epithelium as the presenting feature of neurofibromatosis type 2 (Wishart Type). J Pediatr Ophthalmol Strabismus. 2014; 51 Online:doi: 10.3928/01913913-20140521-02.